ProFund Advisors »

Day One Biopharmaceuticals I shares owned by ProFund Advisors

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $380k 28k 13.78
2024-03-31 $506k 31k 16.52
2023-09-30 $494k 40k 12.27
2023-06-30 $628k 53k 11.94
2023-03-31 $472k 35k 13.37

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Qualcomm (QCOM)
Applied Materials (AMAT)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Texas Instruments Incorporated (TXN)

View all positions for ProFund Advisors

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Braidwell
BlackRock
Vanguard Group
BlackRock
Franklin Resources
Fairmount Funds Management
Pictet Asset Management Holding SA
State Street Corporation
Estuary Capital Management
Deerfield Management Company
Viking Global Investors
T. Rowe Price Associates
Vestal Point Capital

View all funds holding Day One Biopharmaceuticals I